Concord Medical Services Corporate Bonds and Leverage Analysis

CCM Stock  USD 4.68  0.41  8.06%   
Concord Medical Services holds a debt-to-equity ratio of 1.247. At this time, Concord Medical's Debt To Assets are very stable compared to the past year. As of the 2nd of December 2024, Total Debt To Capitalization is likely to grow to 3.43, though Net Debt To EBITDA is likely to grow to (11.76). . Concord Medical's financial risk is the risk to Concord Medical stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

Concord Medical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Concord Medical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Concord Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Concord Medical's stakeholders.
For most companies, including Concord Medical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Concord Medical Services, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Concord Medical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
3.0038
Book Value
(489.59)
Operating Margin
(0.90)
Profit Margin
(0.80)
Return On Assets
(0.04)
At this time, Concord Medical's Total Current Liabilities is very stable compared to the past year. As of the 2nd of December 2024, Change To Liabilities is likely to grow to about 206.4 M, while Liabilities And Stockholders Equity is likely to drop about 4.3 B.
  
Check out the analysis of Concord Medical Fundamentals Over Time.
View Bond Profile
Given the importance of Concord Medical's capital structure, the first step in the capital decision process is for the management of Concord Medical to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Concord Medical Services to issue bonds at a reasonable cost.

Concord Medical Bond Ratings

Concord Medical Services financial ratings play a critical role in determining how much Concord Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Concord Medical's borrowing costs.
Piotroski F Score
4
PoorView
Beneish M Score
(4.01)
Unlikely ManipulatorView

Concord Medical Services Debt to Cash Allocation

Many companies such as Concord Medical, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Concord Medical Services has 3.3 B in debt with debt to equity (D/E) ratio of 1.25, which is OK given its current industry classification. Concord Medical Services has a current ratio of 0.7, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Concord to invest in growth at high rates of return.

Concord Medical Total Assets Over Time

Concord Medical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Concord Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Concord Medical Debt Ratio

    
  53.0   
It appears that about 47% of Concord Medical's assets are financed be debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Concord Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Concord Medical, which in turn will lower the firm's financial flexibility.

Concord Medical Corporate Bonds Issued

Concord Long Term Debt

Long Term Debt

2.11 Billion

At this time, Concord Medical's Long Term Debt is very stable compared to the past year.

Understaning Concord Medical Use of Financial Leverage

Leverage ratios show Concord Medical's total debt position, including all outstanding obligations. In simple terms, high financial leverage means that the cost of production, along with the day-to-day running of the business, is high. Conversely, lower financial leverage implies lower fixed cost investment in the business, which is generally considered a good sign by investors. The degree of Concord Medical's financial leverage can be measured in several ways, including ratios such as the debt-to-equity ratio (total debt / total equity), or the debt ratio (total debt / total assets).
Last ReportedProjected for Next Year
Long Term DebtB2.1 B
Short and Long Term Debt Total3.3 B3.5 B
Net Debt3.2 B3.4 B
Short Term Debt1.1 B1.1 B
Short and Long Term DebtB537.8 M
Long Term Debt Total2.5 B2.6 B
Net Debt To EBITDA(12.38)(11.76)
Debt To Equity(1.44)(1.51)
Interest Debt Per Share 737.53  774.41 
Debt To Assets 0.50  0.53 
Long Term Debt To Capitalization(18.66)(17.73)
Total Debt To Capitalization 3.27  3.43 
Debt Equity Ratio(1.44)(1.51)
Debt Ratio 0.50  0.53 
Cash Flow To Debt Ratio(0.09)(0.09)
Please read more on our technical analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
Check out the analysis of Concord Medical Fundamentals Over Time.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.97)
Revenue Per Share
107.978
Quarterly Revenue Growth
(0.23)
Return On Assets
(0.04)
Return On Equity
(0.32)
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.